Travere Therapeutics, Inc.
TVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438533
In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Travere Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 148
- +13 vs. Q2 2021
- Shares held
- 60.9M
- −30.8K (−0.1%) vs. Q2 2021
- Total value
- $1.48B
- +$581.1M (+64.9%) vs. Q2 2021
- New holders
- 34
- 43 more added
- Sold out
- 21
- 53 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $5.98B |
| Q1 2026 | 261 | $3.01B |
| Q4 2025 | 278 | $3.90B |
| Q3 2025 | 238 | $2.41B |
| Q2 2025 | 213 | $1.49B |
| Q1 2025 | 218 | $1.77B |
| Q4 2024 | 197 | $1.66B |
| Q3 2024 | 178 | $1.16B |
| Q2 2024 | 174 | $723.4M |
| Q1 2024 | 175 | $677.4M |
| Q4 2023 | 165 | $769.6M |
| Q3 2023 | 169 | $737.2M |
| Q2 2023 | 169 | $1.27B |
| Q1 2023 | 175 | $1.89B |
| Q4 2022 | 155 | $1.53B |
| Q3 2022 | 171 | $1.72B |
| Q2 2022 | 171 | $1.68B |
| Q1 2022 | 169 | $1.79B |
| Q4 2021 | 169 | $2.04B |
| Q3 2021 | 148 | $1.48B |
| Q2 2021 | 136 | $900.8M |
| Q1 2021 | 150 | $1.56B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Travere Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eaton Vance Management | 177,721 | $4.31M | 0.01% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 200,000 | $4.85M | 1.93% | +200,000 | New |
| Soleus Capital Management, L.P. | 210,815 | $5.11M | 0.80% | +210,815 | New |
| Tekla Capital Management LLC | 212,869 | $5.16M | 0.17% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 223,250 | $5.41M | 0.00% | +19,796+9.7% | Added |
| Citigroup Inc | 235,827 | $5.72M | 0.01% | +25,308+12.0% | Added |
| Public Sector Pension Investment Board | 238,000 | $5.77M | 0.03% | +107,000+81.7% | Added |
| Polar Asset Management Partners Inc. | 257,500 | $6.24M | 0.07% | +257,500 | New |
| Thrivent Financial for Lutherans | 262,792 | $6.37M | 0.01% | +262,792 | New |
| Healthcare of Ontario Pension Plan Trust Fund | 269,600 | $6.54M | 0.02% | −2,400−0.9% | Reduced |
| MPM Oncology Impact Management LP | 306,515 | $7.43M | 1.15% | +306,515 | New |
| GW&K Investment Management, LLC | 310,518 | $7.53M | 0.07% | −4,231−1.3% | Reduced |
| Deutsche Bank AG | 340,847 | $8.27M | 0.00% | −1,082−0.3% | Reduced |
| Cormorant Asset Management, LP | 350,000 | $8.49M | 0.34% | +350,000 | New |
| Pictet Asset Management SA | 354,163 | $8.59M | 0.01% | +354,163 | New |
| FMR LLC | 372,928 | $9.04M | 0.00% | +360,629+2,932.2% | Added |
| International Biotechnology Trust PLC | 380,000 | $9.21M | 2.26% | +360,000+1,800.0% | Added |
| Morgan Stanley | 380,935 | $9.24M | 0.00% | +243,852+177.9% | Added |
| D. E. Shaw & Co., Inc. | 405,837 | $9.84M | 0.01% | −791,961−66.1% | Reduced |
| Sofinnova Investments, Inc. | 437,280 | $10.6M | 0.68% | +437,280 | New |
| Canada Pension Plan Investment Board | 458,000 | $11.1M | 0.01% | +100,000+27.9% | Added |
| Charles Schwab Investment Management Inc | 463,879 | $11.3M | 0.00% | −176,236−27.5% | Reduced |
| Nuveen Asset Management, LLC | 476,545 | $11.8M | 0.00% | −196,772−29.2% | Reduced |
| Northern Trust Corp | 560,615 | $13.6M | 0.00% | −58,130−9.4% | Reduced |
| Great Point Partners LLC | 625,000 | $15.2M | 3.58% | −459,300−42.4% | Reduced |
| Mangrove Partners | 652,372 | $15.8M | 1.75% | +357,335+121.1% | Added |
| Manufacturers Life Insurance Company, The | 705,925 | $17.1M | 0.01% | −3,577−0.5% | Reduced |
| Laurion Capital Management LP | 758,951 | $18.4M | 0.27% | +191,768+33.8% | Added |
| Citadel Advisors LLC | 802,370 | $19.5M | 0.02% | +777,966+3,187.9% | Added |
| Bank of America Corp | 955,430 | $23.2M | 0.00% | −717,055−42.9% | Reduced |
| Dimensional Fund Advisors LP | 970,470 | $23.5M | 0.01% | −176,356−15.4% | Reduced |
| JPMorgan Chase & Co | 976,140 | $23.7M | 0.00% | −80,384−7.6% | Reduced |
| Geode Capital Management, LLC | 983,978 | $23.9M | 0.00% | −21,461−2.1% | Reduced |
| Jacobs Levy Equity Management, Inc | 1,032,398 | $25.0M | 0.17% | +241,467+30.5% | Added |
| Goldman Sachs Group Inc | 1,093,322 | $26.5M | 0.01% | −1,363,958−55.5% | Reduced |
| Renaissance Technologies LLC | 1,240,418 | $30.1M | 0.04% | −470,904−27.5% | Reduced |
| Rock Springs Capital Management LP | 1,496,817 | $36.3M | 0.76% | +2,653+0.2% | Added |
| Adage Capital Partners GP, L.L.C. | 1,700,000 | $41.2M | 0.08% | −1,893,763−52.7% | Reduced |
| VR Adviser, LLC | 1,732,410 | $42.0M | 5.40% | +1,732,410 | New |
| Perceptive Advisors LLC | 1,965,555 | $47.7M | 0.69% | +120,000+6.5% | Added |
| Baker Bros. Advisors LP | 2,039,772 | $49.5M | 0.22% | +1,852,857+991.3% | Added |
| State Street Corp | 2,782,323 | $67.5M | 0.00% | −671,536−19.4% | Reduced |
| Vanguard Group Inc | 3,865,481 | $93.7M | 0.00% | +30,725+0.8% | Added |
| Macquarie Group Ltd | 3,951,841 | $95.8M | 0.08% | +39,428+1.0% | Added |
| Janus Henderson Group PLC | 4,023,074 | $97.6M | 0.04% | +117,961+3.0% | Added |
| BlackRock Inc. | 4,562,850 | $110.6M | 0.00% | −429,675−8.6% | Reduced |
| Armistice Capital, LLC | 4,748,000 | $115.1M | 2.85% | −1,000,000−17.4% | Reduced |
| Ra Capital Management, L.P. | 5,614,428 | $136.2M | 1.89% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −143,900−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −125,437−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −105,998−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −84,064−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −61,500−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −49,400−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −32,469−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −22,761−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −22,778−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −19,990−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −10,989−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −10,545−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −11,248−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −10,042−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,469−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −887−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |